BIBW-2948

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameBIBW-2948
Drug Alias NameBIBW-2948BIBW-2948-BS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveBronchitis, Chronic

Other Information

ATC CodeN/A
Related LinksN/A